SitesBLAST
Comparing WP_036833248.1 NCBI__GCF_000775615.1:WP_036833248.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
P07117 Sodium/proline symporter; Proline carrier; Proline permease; Propionate transporter from Escherichia coli (strain K12) (see 4 papers)
29% identity, 92% coverage: 5:443/478 of query aligns to 9:447/502 of P07117
- R257 (= R261) mutation to C: Sodium-independent binding affinity for proline.
- C281 (≠ I285) mutation to S: Does not affect proline uptake activity. Confers resistance to N-ethylmaleimide. Na(+)-dependent proline binding activity is similar to wild-type carrier.
- C344 (≠ S340) mutation to S: Small decrease in proline uptake activity. Confers resistance to N-ethylmaleimide. Exhibits low Na(+)-dependent proline binding.
- C349 (≠ V345) mutation to S: Does not affect proline uptake activity. Sensitive to N-ethylmaleimide. Na(+)-dependent proline binding activity is similar to wild-type carrier.
- R376 (≠ F372) mutation R->E,Q: No change in activity.; mutation to K: Loss of activity.
8j74A Human high-affinity choline transporter cht1 in the hc-3-bound outward-facing open conformation, dimeric state (see paper)
24% identity, 90% coverage: 7:434/478 of query aligns to 7:441/515 of 8j74A
- binding Lauryl Maltose Neopentyl Glycol: F203 (≠ T205), S206 (≠ A208), H207 (≠ G209), I213 (= I215), G214 (≠ D218), F215 (≠ L219), H219 (≠ N223), C326 (≠ L318), P327 (= P319)
- binding (2S,2'S)-2,2'-biphenyl-4,4'-diylbis(2-hydroxy-4,4-dimethylmorpholin-4-ium): W60 (≠ Y57), Y89 (= Y89), W139 (≠ I133), L245 (= L247), W252 (≠ H257), W404 (≠ G402), Y405 (≠ G403), S408 (≠ A406)
9bimA Cryo-em structure of human cht1 in the hc-3 bound outward-facing state
24% identity, 90% coverage: 7:434/478 of query aligns to 8:440/516 of 9bimA
- binding (2S,2'S)-2,2'-biphenyl-4,4'-diylbis(2-hydroxy-4,4-dimethylmorpholin-4-ium): W59 (≠ Y57), Y77 (≠ L75), Y88 (= Y89), W138 (≠ I133), W251 (≠ H257), Y404 (≠ G403), S407 (≠ A406)
8zqpA High affinity choline transporter 1
24% identity, 90% coverage: 7:434/478 of query aligns to 6:440/470 of 8zqpA
Q9GZV3 High affinity choline transporter 1; hCHT1; Hemicholinium-3-sensitive choline transporter; CHT; Solute carrier family 5 member 7 from Homo sapiens (Human) (see 5 papers)
24% identity, 90% coverage: 7:434/478 of query aligns to 9:443/580 of Q9GZV3
- D48 (≠ Q43) to G: in CMS20; decreased choline transmembrane transporter activity; no effect on localization at plasma membrane; dbSNP:rs886039768
- G65 (≠ A60) to E: in CMS20; loss of choline transmembrane transporter activity; no effect on localization at plasma membrane; dbSNP:rs886039765
- I89 (≠ T87) to V: 40% reduction in choline transmembrane transporter activity; found in 0.06 of Ashkenazi Jews; dbSNP:rs1013940; mutation to A: Decreased choline transmembrane transporter activity, only 20% of wild-type choline uptake activity.
- P105 (≠ I102) to S: in CMS20; decreased choline transmembrane transporter activity; no effect on localization at plasma membrane; dbSNP:rs886039766
- Y111 (≠ A108) to H: in CMS20; no effect on localization at plasma membrane
- Y175 (= Y174) to C: in CMS20; uncertain significance; dbSNP:rs1331713195
- I291 (≠ M289) to T: in CMS20; uncertain significance; dbSNP:rs375397889
- V344 (≠ I334) to L: in CMS20; uncertain significance
- R361 (≠ K351) to Q: in CMS20; decreased choline transmembrane transporter activity; no effect on localization at plasma membrane; dbSNP:rs147656110
- F418 (≠ W410) to V: in CMS20; uncertain significance
Sites not aligning to the query:
- 446 R → G: in CMS20; decreased choline transmembrane transporter activity; no effect on localization at plasma membrane
- 451 E→Q: Decreased choline transmembrane transporter activity, only 5% of wild-type choline uptake activity.
- 527:532 Dileucine-like motif
- 530 I→A: No change in protein internalization. No change in choline transmembrane transporter activity.
- 531 L→A: Loss of protein internalization to vesicular structures in neurons. Increased choline transmembrane transporter activity.
- 531:532 LV→AA: Decreased protein internalization; when associated with V-538. Increased choline transmembrane transporter activity; when associated with V-538.
- 532 V→A: Decreased protein internalization. Increased choline transmembrane transporter activity.
- 538 K→V: Decreased protein internalization; when associated with 531-L-V-532. Increased choline transmembrane transporter activity; when associated with 531-L-V-532.
Q9NY91 Probable glucose sensor protein SLC5A4; Solute carrier family 5 member 4 from Homo sapiens (Human) (see paper)
22% identity, 76% coverage: 2:365/478 of query aligns to 28:421/659 of Q9NY91
Sites not aligning to the query:
- 457 E→Q: Confers sugar transport activity not found in the wild-type protein. Increased sensitivity to inhibitor phlorizin.
8hezA Structure of human sglt2-map17 complex with dapagliflozin (see paper)
23% identity, 77% coverage: 2:367/478 of query aligns to 2:402/582 of 8hezA
- binding (2S,3R,4R,5S,6R)-2-[4-chloranyl-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol: N55 (≠ Y57), G59 (≠ S61), H60 (≠ S62), G63 (= G65), L64 (≠ G66), T67 (≠ L69), F78 (≠ Y89), E79 (vs. gap), V266 (≠ L247), S267 (≠ V248), W271 (≠ V252), K301 (≠ V282)
- binding sodium ion: A53 (= A55), I56 (≠ G58), G57 (≠ S59), A369 (= A333), S372 (= S336), S373 (≠ T337)
Sites not aligning to the query:
- binding (2S,3R,4R,5S,6R)-2-[4-chloranyl-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol: 433, 437
- binding : 568, 571, 572, 575, 576, 579, 580
Q8N695 Sodium-coupled monocarboxylate transporter 1; Apical iodide transporter; Electrogenic sodium monocarboxylate cotransporter; Sodium iodide-related cotransporter; Solute carrier family 5 member 8 from Homo sapiens (Human) (see 3 papers)
24% identity, 76% coverage: 22:382/478 of query aligns to 34:396/610 of Q8N695
- V193 (≠ G191) to I: in dbSNP:rs1709189
- F251 (vs. gap) to V: in dbSNP:rs11834933
Sites not aligning to the query:
- 608 T→A: Loss of interaction with PDZK1.
- 608:610 PDZ-binding
- 610 L→A: Loss of interaction with PDZK1.
8hdhA Structure of human sglt2-map17 complex with canagliflozin (see paper)
23% identity, 77% coverage: 2:367/478 of query aligns to 2:402/586 of 8hdhA
- binding (2~{S},3~{R},4~{R},5~{S},6~{R})-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methyl-phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol: N55 (≠ Y57), G59 (≠ S61), H60 (≠ S62), G63 (= G65), L64 (≠ G66), F78 (≠ Y89), E79 (vs. gap), S267 (≠ V248), W271 (≠ V252)
- binding sodium ion: A53 (= A55), S54 (≠ T56), I56 (≠ G58), G57 (≠ S59), A369 (= A333), S372 (= S336), S373 (≠ T337)
Sites not aligning to the query:
- binding (2~{S},3~{R},4~{R},5~{S},6~{R})-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methyl-phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol: 433, 434, 437, 506
- binding : 575, 579, 580, 583, 584
8hb0A Structure of human sglt2-map17 complex with ta1887 (see paper)
23% identity, 77% coverage: 2:367/478 of query aligns to 2:402/586 of 8hb0A
- binding (2R,3R,4S,5S,6R)-2-[3-[(4-cyclopropylphenyl)methyl]-4-fluoranyl-indol-1-yl]-6-(hydroxymethyl)oxane-3,4,5-triol: N55 (≠ Y57), H60 (≠ S62), G63 (= G65), L64 (≠ G66), T67 (≠ L69), V75 (= V86), F78 (≠ Y89), E79 (vs. gap), V137 (≠ A143), V266 (≠ L247), S267 (≠ V248), W271 (≠ V252)
- binding sodium ion: A53 (= A55), I56 (≠ G58), G57 (≠ S59), A369 (= A333), S372 (= S336), S373 (≠ T337)
Sites not aligning to the query:
- binding (2R,3R,4S,5S,6R)-2-[3-[(4-cyclopropylphenyl)methyl]-4-fluoranyl-indol-1-yl]-6-(hydroxymethyl)oxane-3,4,5-triol: 433, 437
- binding : 575, 576, 579, 580, 583, 584
7vsiA Structure of human sglt2-map17 complex bound with empagliflozin (see paper)
23% identity, 77% coverage: 2:367/478 of query aligns to 2:402/586 of 7vsiA